G-Amp℠ On & Off-Target Editing Verification
G-Amp℠ On & Off-Target Editing Verification
- Proprietary G-Amp℠ platform
- Over 90% of on-target projects delivered within 1 week
- Off-target panels developed in as little as 4 weeks
- Unique Molecular ID (UMI) designed to enhance accuracy by removing PCR-introduced artifacts
- Dual amplicon options to achieve sensitivity of 0.01% or better
- Fully validated panels for GLP/GMP-compliant testing supporting drug development, manufacturing, clinical trials, and patient testing